An observational study in Photoprotection, Sunscreen and Sunscreen Agents, sponsored by Venus Research Center. Enrolling by invitation at 1 site in Egypt. Open to participants aged 25 Years and older. Per ClinicalTrials.gov, last updated 2025-12-22.
Sponsored by Venus Research Center · Observational
This study is a Delphi-based expert consensus project aimed at developing evidence-informed recommendations for photoprotection practices across various populations, including general, at-risk, and special groups (e.g., children, pregnant women, patients with photodermatoses). Despite extensive evidence on the importance of sun protection, there is variability in clinical advice regarding sunscreen selection, application frequency, SPF requirements, adjunctive protective measures, and patient counseling.
This study is a non-interventional, methodological Delphi consensus project designed to develop standardized recommendations for photoprotection practices. Photoprotection encompasses strategies to minimize ultraviolet (UV)-related skin damage, including sunscreen use, clothing, behavioral measures, and patient education. Despite broad awareness campaigns, inconsistencies exist regarding SPF selection, application methods, timing, reapplication frequency, and the use of additional protective measures.
A steering committee of dermatologists and photoprotection experts will conduct a literature review and draft initial statements addressing key domains:
Sunscreen use: SPF level, spectrum coverage (UVA/UVB), formulation (chemical vs. physical), water resistance.
Application guidelines: Amount, timing before sun exposure, reapplication frequency, body coverage.
Adjunctive measures: Protective clothing, hats, sunglasses, shade-seeking behavior.
Special populations: Children, pregnant women, outdoor workers, patients with photosensitive dermatoses.
Behavioral counseling: Education strategies, adherence promotion, and misconceptions.
Integration with skin care and aesthetic practices.
A panel of experts in dermatology, photobiology, and related fields will participate in multiple Delphi rounds. Panelists will rate agreement with each statement using a Likert scale. Anonymized feedback will be provided after each round, and statements not reaching a predefined consensus threshold (e.g., ≥70-80%) will be revised and re-evaluated in subsequent rounds.
The final output will consist of consensus-based recommendations reflecting practical, safe, and evidence-informed photoprotection practices. Areas of disagreement or uncertainty will also be highlighted, identifying research gaps and priorities for future studies.
Venus Research Center is the lead sponsor of 11 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population will consist of a purposive sample of experts in dermatology, photobiology, and related fields who are actively involved in photoprotection research, clinical practice, or public health initiatives. Panelists should have experience advising patients or populations on sun protection, sunscreen use, and UV-related skin care.
Panel Size and Rationale:
Target enrollment: 20-35 experts
Sufficient to capture diverse perspectives while remaining manageable for multiple Delphi rounds.
Minimum for analysis: 15 panelists, ensuring representativeness in case of attrition
Board-certified dermatologists, photobiologists, or clinicians/researchers with ≥5 years of relevant experience.
Regular involvement in advising on photoprotection, skin cancer prevention, or UV-related dermatology.
Engagement in research, guideline development, teaching, or professional society activities related to dermatology, photobiology, or public health.
Willingness and availability to participate in all Delphi rounds.
Exclusion Criteria:
Less than 5 years of relevant clinical or research experience.
Limited or no experience with photoprotection counseling or research.
Significant undisclosed conflict of interest related to sunscreen or photoprotection products.
Inability or unwillingness to participate in all Delphi rounds.
The study population will consist of a purposive sample of dermatologists, photobiologists, and other experts actively involved in photoprotection research, clinical practice, or public health initiatives. Panelists should have experience advising patients or the public on sunscreen use, UV protection strategies, or photodermatoses. Panel Size and Rationale: Target enrollment: 20-35 experts Large enough to capture diverse perspectives while remaining feasible for iterative Delphi rounds. Minimum for analysis: 15 panelists to ensure adequate representativeness in case of attrition.
Primary Outcome
Level of expert consensus on statements regarding photoprotection practices, measured as the proportion of panelists reaching the predefined agreement threshold (e.g., ≥70-80%) per statement across Delphi rounds.
Time frame: 6-12 weeks
Secondary Outcomes
Consensus on sunscreen use: SPF level, broad-spectrum coverage, formulation, and water resistance. Consensus on application guidelines: amount, timing before sun exposure, reapplication frequency, body coverage. Consensus on adjunctive measures: protective clothing, hats, sunglasses, shade-seeking behavior. Consensus on special populations: children, pregnant women, outdoor workers, photosensitive patients. Consensus on behavioral counseling and education strategies for adherence. Identification of areas of uncertainty requiring further research or regional adaptation.
Time frame: 6-12 weeks
Plan to share: No — Delphi studies do not collect patient data, medical records, biological samples, or identifiable clinical information. Experts only give opinions, not "IPD." Their responses are anonymized, and sharing identifiable expert-level responses is not required and often discouraged
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Venus Research Center